RESUMEN
AIMS/HYPOTHESIS: The aim of this prospective trial was to compare the effect of different long-acting insulin preparations injected at bedtime on glucose concentrations in patients with type 2 diabetes omitting breakfast and lunch the next day. METHODS: Twenty patients (ten women) with type 2 diabetes who were on an intensified insulin therapy participated. Mean (+/-SD) age was 63 +/- 10 years, diabetes duration 18 +/- 9 years, BMI 32.5 +/- 5 kg/m(2), and HbA(1c) 7.3 +/- 0.7%. Patients received neutral protamine Hagedorn (NPH) insulin, insulin detemir or insulin glargine for at least 2 months; doses were adjusted to achieve morning blood glucose levels of <7 mmol/l. At the end of the respective treatment period, the long-acting insulin was injected at bedtime (at 22:45 hours) as usual but patients refrained from breakfast and lunch the next day; glucose was measured by a continuous glucose monitoring system (CGMS). RESULTS: Comparable glucose target ranges were reached at midnight (5.8 to 6.1 mmol/l) and at 07:00 hours (6.7 to 6.9 mmol/l) with all three insulin preparations, using mean doses of 29 +/- 10 U (NPH insulin), 33 +/- 13 U (insulin detemir), and 32 +/- 12 U (insulin glargine). Glucose levels between midnight and 07:00 hours were not significantly different for the three insulin preparations. Symptomatic hypoglycaemia did not occur from 08:00 to 16:00 hours; glucose concentrations during this time were slightly lower with NPH insulin than with insulin detemir (p = 0.012) and insulin glargine (p = 0.049). CONCLUSIONS/INTERPRETATION: Following bedtime injection of NPH insulin or of the analogues insulin detemir or insulin glargine, fasting glucose <7 mmol/l was achieved in the morning, without subsequent hypoglycaemia when participants continued to fast during the day.
Asunto(s)
Diabetes Mellitus Tipo 2/tratamiento farmacológico , Ayuno/fisiología , Insulina Isófana/uso terapéutico , Insulina de Acción Prolongada/uso terapéutico , Edad de Inicio , Anciano , Glucemia/efectos de los fármacos , Glucemia/metabolismo , Péptido C/sangre , Creatinina/sangre , Esquema de Medicación , Femenino , Hemoglobina Glucada/metabolismo , Humanos , Hipoglucemiantes/uso terapéutico , Insulina/análogos & derivados , Insulina/uso terapéutico , Insulina Glargina , Masculino , Persona de Mediana EdadAsunto(s)
Sustitución de Medicamentos/métodos , Enfermedad de Fabry/tratamiento farmacológico , Isoenzimas/administración & dosificación , alfa-Galactosidasa/administración & dosificación , Progresión de la Enfermedad , Monitoreo de Drogas/métodos , Ecocardiografía , Terapia de Reemplazo Enzimático/métodos , Enfermedad de Fabry/sangre , Enfermedad de Fabry/diagnóstico , Enfermedad de Fabry/fisiopatología , Tasa de Filtración Glomerular , Humanos , Masculino , Resultado del TratamientoRESUMEN
Iron deficiency (ID) without anaemia frequently remains undiagnosed when symptoms are attributed to ID with anaemia. Serum ferritin is the primary diagnostic parameter, whereas <10 microg/l represent depleted iron stores, 10-30 microg/l can confirm ID without anaemia and 30-50 microg/l might indicate functional ID. In case of increased CRP or ALT, normal/elevated ferritin should be interpreted with caution. IV iron is indicated if oral iron is not effective or tolerated. At ferritin <10 microg/l, a cumulative dose of 1000 mg iron and at ferritin 10-30 microg/l, a cumulative dose of 500 mg is advised. At ferritin 30-50 microg/l a first dose of 200 mg might be considered. Ferritin shall be reassessed not sooner than 2 weeks after the last oral or 8-12 weeks after the last IV iron administration.
Asunto(s)
Deficiencias de Hierro , Enfermedades Carenciales/diagnóstico , Enfermedades Carenciales/tratamiento farmacológico , HumanosAsunto(s)
Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Insulina/análogos & derivados , Insulina/uso terapéutico , Obesidad/tratamiento farmacológico , Sustitución de Aminoácidos , Relación Dosis-Respuesta a Droga , Humanos , Hipoglucemiantes/uso terapéutico , Insulina/genética , Insulina Detemir , Insulina Glargina , Insulina Isófana/uso terapéutico , Insulina de Acción ProlongadaAsunto(s)
Anticoagulantes/administración & dosificación , Enfermedades de las Válvulas Cardíacas/cirugía , Prótesis Valvulares Cardíacas , Complicaciones Posoperatorias/prevención & control , Tromboembolia/prevención & control , Anticoagulantes/efectos adversos , Anticoagulantes/farmacocinética , Bioprótesis , Femenino , Enfermedades de las Válvulas Cardíacas/sangre , Enfermedades de las Válvulas Cardíacas/mortalidad , Hemorragia/sangre , Hemorragia/inducido químicamente , Hemorragia/mortalidad , Hemorragia/prevención & control , Humanos , Cuidados a Largo Plazo , Complicaciones Posoperatorias/sangre , Complicaciones Posoperatorias/mortalidad , Embarazo , Diseño de Prótesis , Factores de Riesgo , Tasa de Supervivencia , Tromboembolia/sangre , Tromboembolia/mortalidadRESUMEN
Iron deficiency (ID) without anaemia frequently remains undiagnosed when symptoms are attributed to ID with anaemia. Serum ferritin is the primary diagnostic parameter, whereas <10 microg/l represent depleted iron stores, 10-30 microg/l can confirm ID without anaemia and 30-50 microg/l might indicate functional ID. In case of increased CRP or ALT, normal/elevated ferritin should be interpreted with caution. Intravenous iron is indicated if oral iron is not effective or tolerated. At ferritin <10 microg/l, a cumulative dose of 1000 mg iron and at ferritin 10-30 microg/l, a cumulative dose of 500 mg is advised. At ferritin 30-50 microg/l a first dose of 200 mg might be considered. Ferritin shall be reassessed not sooner than 2 weeks after the last oral or 8-12 weeks after the last iv iron administration.
Asunto(s)
Anemia Ferropénica/diagnóstico , Deficiencias de Hierro , Alopecia/sangre , Alopecia/etiología , Anemia Ferropénica/sangre , Trastornos del Conocimiento/sangre , Trastornos del Conocimiento/etiología , Estudios Transversales , Diagnóstico Diferencial , Formas de Dosificación , Fatiga/sangre , Fatiga/etiología , Ferritinas/sangre , Humanos , Hierro/administración & dosificación , Hierro/sangre , Compuestos de Hierro/administración & dosificación , Compuestos de Hierro/efectos adversos , Valores de Referencia , Síndrome de las Piernas Inquietas/sangre , Síndrome de las Piernas Inquietas/etiologíaAsunto(s)
Enfermedades Gastrointestinales/diagnóstico , Hemorragia Gastrointestinal/etiología , Melena/etiología , Anciano , Algoritmos , Anastomosis en-Y de Roux , Angiografía , Endoscopía Capsular , Causas de Muerte , Diagnóstico Diferencial , Enteroscopía de Doble Balón , Endoscopía Gastrointestinal , Femenino , Hemorragia Gastrointestinal/diagnóstico , Hemorragia Gastrointestinal/mortalidad , Humanos , Melena/diagnóstico , Melena/mortalidad , Persona de Mediana Edad , Complicaciones Posoperatorias/diagnóstico , Cintigrafía , Recto , Factores de Riesgo , Tasa de Supervivencia , Várices/diagnósticoAsunto(s)
Deficiencia de Vitamina B 12/diagnóstico , Administración Oral , Biopsia , Estudios Transversales , Diagnóstico Diferencial , Mucosa Gástrica/patología , Gastritis/complicaciones , Gastritis/diagnóstico , Gastritis/patología , Gastroscopía , Humanos , Inyecciones Intramusculares , Masculino , Persona de Mediana Edad , Necesidades Nutricionales , Factores de Riesgo , Vitamina B 12/administración & dosificación , Deficiencia de Vitamina B 12/tratamiento farmacológico , Deficiencia de Vitamina B 12/etiologíaAsunto(s)
Enfermedades Neuromusculares/diagnóstico , Esclerosis Amiotrófica Lateral/diagnóstico , Diagnóstico Diferencial , Progresión de la Enfermedad , Distonía/etiología , Fasciculación/etiología , Humanos , Masculino , Persona de Mediana Edad , Mioclonía/etiología , Miocimia/etiología , Examen Neurológico , Tics/etiología , Temblor/etiologíaRESUMEN
A 20-year old student had suffered since 3 years from diabetes mellitus type I, which was well-controlled by insulin-pump therapy. During a flight from Moscow to Los Angeles, the student all of a sudden had chest pain, dyspnea, and he vomitted repetitively--emergency landing at Zurich airport was necessary. The student presented at the emergency unit in a poor general condition with tachypnea (32/min) and tachycardia (136/min). Arterial blood gas analysis showed severe metabolic acidosis (pH 7.04), while pulmonary or cardiac disease could be ruled out. Diabetic ketoacidosis was caused by the pump running short of insulin. Treatment included rehydration and administration of insulin. Administration of insulin by an insulin-pump allows to continuously and flexibly adjust the dosage according to the requirement of the body. Interruption of insulin administration can cause, however, relatively fast ketoacidosis because exclusively short-acting insulin is used.
Asunto(s)
Aeronaves , Dolor en el Pecho/etiología , Diabetes Mellitus Tipo 1/diagnóstico , Cetoacidosis Diabética/diagnóstico , Disnea/etiología , Urgencias Médicas , Insulina/análogos & derivados , Viaje , Vómitos/etiología , Adulto , Glucemia/metabolismo , Diabetes Mellitus Tipo 1/tratamiento farmacológico , Cetoacidosis Diabética/tratamiento farmacológico , Diagnóstico Diferencial , Electrocardiografía , Humanos , Inyecciones Intravenosas , Insulina/administración & dosificación , Sistemas de Infusión de Insulina , Insulina Lispro , Masculino , Taquicardia Sinusal/etiologíaRESUMEN
A 75-year old woman with essential hypertension presented two days after the onset of a sudden and strong thoracic pain. The pain did neither increase during breathing nor decrease after the ingestion of nitroglycerine, and could not be triggered by physical manipulation of the thoracic wall. Electrocardiogram showed a left bundle branch block, chest X-ray showed a widened upper mediastinum. Rupture/dissection of an aberrant right subclavian artery (a. lusoria) could be diagnosed by computed tomography. Successful implantation of an endovascular stent-graft was carried out. Evaluation of (sub)acute thoracic pain should include two-plane chest X-ray and, in case of a widened mediastinum, further investigation by computed tomography. In case of highly suspected rupture/dissection of an intrathoracic artery, a specific imaging procedure such as computed tomography is crucial.
Asunto(s)
Aneurisma Roto/diagnóstico , Disección Aórtica/diagnóstico , Dolor en el Pecho/etiología , Arteria Subclavia , Tomografía Computarizada por Rayos X , Anciano , Disección Aórtica/terapia , Aneurisma Roto/terapia , Angioplastia de Balón , Bloqueo de Rama/diagnóstico , Electrocardiografía , Femenino , Humanos , Stents , Arteria Subclavia/anomalíasRESUMEN
After his girl friend had been diagnosed with active pulmonary tuberculosis, a 45-year old male was referred to rule out transmission of this disease. The chest x-ray showed no signs of tuberculosis, however a small retrosternal lung nodule was found on the lateral film. Three months later, the nodule showed an increase in size and a CT of the chest was performed: No nodule could be found in the expected retrosternal location, but incidentally a small nodule in the right upper lobe was identified. This nodule could retrospectively be identified on the previous chest X-rays, its size had been increasing. After surgical removal, the lesion was diagnosed to be an adenocarcinoma T1, N0, M0. Careful follow-up of small intrapulmonary nodules detected on chest X-rays is highly advisable, especially in smokers of middle and older age bronchial carcinoma and therefore a straight forward approach with excision of the nodule should be considered. Nodules have to be surgically removed if an increase in size can be noted.